But the primary endpoint of this study is the change in EF and secondary end-points were death and hospitalization for heart failure, atrial fibrillation (AF) burden, changes in brain natriuretic peptide (BNP) levels, and 6-min walk test. This evidence concerns the gene NPPB and heart failure.